<DOC>
	<DOCNO>NCT01012232</DOCNO>
	<brief_summary>In randomize , double-blind , cross-over trial , 48 patient schedule total knee arthroplasty placement intracapsular catheter randomize receive bolus injection ropivacaine high volume/low concentration ( 20 ml , 5 mg/mL ) low volume/high concentration ( 10 mL , 10 mg/mL ) 6 24 hour postoperatively , pain assess rest mobilization 2 hour injection .</brief_summary>
	<brief_title>Local Anesthetic Total Knee Arthroplasty ( TKA ) : Volume Versus Concentration</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<criteria>Scheduled total knee arthroplasty Able give inform oral write consent participate Treatment opioids steroid , rheumatoid arthritis immunological disease History stroke neurological psychiatric disease potentially influence pain perception ( e.g . depression , diabetic neuropathy etc . ) Allergies drug administer .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>total knee arthroplasty</keyword>
	<keyword>postoperative pain</keyword>
</DOC>